Literature DB >> 15510815

[Extrapleural pneumonectomy after hyperthermo-chemotherapy for the lung cancer patients with malignant pleural effusion].

Kazuya Suzuki1, K Funai, Y Shundo, K Asano, K Takamochi, K Asai, T Kazui, K Miura.   

Abstract

The prognosis of the lung cancer patients with malignant pleural effusion is extremely poor. Intrapleural perfusion hyperthermo-chemotherapy for the treatment of malignant pleural effusion was performed in 120 lung cancer patients and showed better prognosis than conventional treatment. After successful local control by hyperthermo-chemotherapy, extrapleural pneumonectomy was performed in 8 patients with clinical N 0 or N 1 and M 0 lung cancer. All patients survived for more than 1 year. The only 1 patient survived for more than 3 years and 3 months without recurrence. Almost all patients who died within 2 years had pathological n 2, carcinomatous pericarditis, cancer invasion beyond extrapleural space and so on. Extrapleural pneumonectomy after hyperthermo-chemotherapy can be a choice of surgical treatment if the n 2 disease, pericarditis, and extrapleural invasion of disseminated cancer cells should be excluded precisely.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15510815

Source DB:  PubMed          Journal:  Kyobu Geka        ISSN: 0021-5252


  2 in total

1.  Intrapleural hyperthermic perfusion using distilled water at 48 °C for malignant pleural effusion.

Authors:  Mingchen Ba; Hui Long; Yuandong Wang; Yunqiang Tang; Yinbing Wu; Xiangliang Zhang; Shuzhong Cui
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-26       Impact factor: 4.553

2.  The efficacy and safety of intrapleural hyperthermic perfusion in patients with malignant pleural effusion undergoing video-assisted thoracic surgery: a single-arm clinical trial.

Authors:  Xinxin Wang; Min Kong; Jiang Jin; Yulian Lin; Limin Jia; Minhua Ye
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.